Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis.
Poncet B, Bachelot T, Colin C, Ganne C, Jaisson-Hot I, Orfeuvre H, Peaud PY, Jacquin JP, Salles B, Tigaud JD, Mechin-Cretinon I, Marechal F, Fournel C, Trillet-Lenoir V.
Poncet B, et al. Among authors: ganne c.
Am J Clin Oncol. 2008 Aug;31(4):363-8. doi: 10.1097/COC.0b013e3181637356.
Am J Clin Oncol. 2008.
PMID: 18845995